Irritable Bowel Syndrome
📧 Sign up to get email alerts when something new happens for Irritable Bowel Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-10-31Clinical Trial Update: Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation [Phase 3]
Phase 3 trial update on the efficacy and safety of lubiprostone in irritable bowel syndrome with constipation.
-
CLINICAL_TRIALS trial_result · 2008-10-16Clinical Trial Update: A Randomized Controlled Pilot Trial of Mesalazine in Patients With Irritable Bowel Syndrome [Phase 2, Phase 3]
This clinical trial update notes that a randomized, controlled pilot study of Mesalazine in Irritable bowel syndrome has completed Phase 2 a…
-
CLINICAL_TRIALS trial_result · 2008-10-16Clinical Trial Update: A Study To Investigate The Effect Of Solabegron (GW427353) On Gastrointestinal Transit In Healthy Volunteers [Phase 1]
A Phase 1 study evaluating the effect of solabegron (GW427353) on gastrointestinal transit in healthy volunteers has completed.
-
CLINICAL_TRIALS trial_result · 2008-10-01Clinical Trial Update: Efficacy and Safety of Meteospasmyl® in Irritable Bowel Syndrome [Phase 4]
A Phase 4 clinical trial evaluated the efficacy and safety of Meteospasmyl for irritable bowel syndrome, and the study has completed.
-
CLINICAL_TRIALS trial_result · 2008-09-26Clinical Trial Update: A Study of BMS-562086 in Patients With Irritable Bowel Syndrome [Phase 2]
The update confirms the completion of a Phase 2 trial of BMS-562086 in patients with Irritable Bowel Syndrome.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2008-08-28FDA Approved: DICYCLOMINE HYDROCHLORIDE — Supplemental Application (Endo USA, Inc.)
FDA approved a supplemental application for dicyclomine hydrochloride from Endo USA, Inc., indicating an approved modification or addition t…
-
CLINICAL_TRIALS research · 2008-08-20Clinical Trial Update: Effect of Bifidobacterium on Irritable Bowel Syndrome [NA]
The document describes a clinical trial assessing the effect of the probiotic Bifidobacterium on irritable bowel syndrome. The status is lis…
-
CLINICAL_TRIALS trial_result · 2008-07-08Clinical Trial Update: Long-Term Safety of Renzapride in Women With Constipation-Predominant Irritable Bowel Syndrome (IBS-C) [Phase 3]
Phase 3 long-term safety update for Renzapride in women with constipation-predominant irritable bowel syndrome; the trial was terminated.
-
CLINICAL_TRIALS trial_result · 2008-06-17Clinical Trial Update: Efficacy, Safety and Tolerability of DNK333 (25 and 100 mg Bid) in Women With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) [Phase 2]
Phase 2 trial evaluating DNK333 (25 mg and 100 mg bid) in women with diarrhea-predominant irritable bowel syndrome reported efficacy, safety…
-
CLINICAL_TRIALS trial_result · 2008-06-17Clinical Trial Update: A Study To Investigate The Effect Of PD-217,014 On Abdominal Pain/Discomfort In Patients With IBS. [Phase 2]
A Pfizer-sponsored Phase 2 clinical trial (PD-217,014) evaluating abdominal pain in irritable bowel syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2008-05-14Clinical Trial Update: DARWIN Study: A Randomization/Withdrawal Efficacy Study of Dexloxiglumide in Constipation-Predominant Irritable Bowel Syndrome (C-IBS) [Phase 3]
The DARWIN Phase 3 trial of Dexloxiglumide for constipation-predominant irritable bowel syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2008-05-13Clinical Trial Update: The Efficacy of Herbal Medicine in Relieving Symptoms and Change of Quality of Life of Patients With Irritable Bowel Syndrome (IBS) [Phase 2]
This Phase 2 clinical trial evaluated the efficacy of an unspecified herbal medicine in relieving symptoms and improving quality of life for…
-
CLINICAL_TRIALS trial_result · 2008-04-04Clinical Trial Update: Study to Determine the Effectiveness of the Probiotic E. Coli Strain M17 in Treating Irritable Bowel Syndrome (IBS) [Phase 2]
A Phase 2 clinical trial evaluating the effectiveness of the probiotic Escherichia coli M17 in treating Irritable bowel syndrome has complet…
-
FDA approval · 2008-04-01FDA Approved: LOTRONEX — Supplemental Application (Legacy Pharma USA Inc.)
FDA approved a supplemental application for Lotronex (alosetron hydrochloride) from Legacy Pharma USA Inc.
-
CLINICAL_TRIALS trial_result · 2008-03-18Clinical Trial Update: Rifaximin for the Treatment of Irritable Bowel Syndrome [Phase 2]
Phase 2 trial evaluating rifaximin for irritable bowel syndrome has completed. The update summarizes the trial results.
-
FDA approval · 2008-02-29FDA Approved: DICYCLOMINE HYDROCHLORIDE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for dicyclomine hydrochloride that will allow its sale by Lannett Company, Inc.
-
FDA approval · 2008-02-29FDA Approved: DICYCLOMINE HYDROCHLORIDE — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for Lannett Company's generic dicyclomine hydrochloride product. This confirms regulatory approv…
-
CLINICAL_TRIALS trial_result · 2008-02-25Clinical Trial Update: Pilot Study to Assess the Effects of AV608 on Irritable Bowel Syndrome [Phase 1]
A Phase 1 pilot study evaluating AV608 for irritable bowel syndrome has been terminated.
-
CLINICAL_TRIALS trial_result · 2008-02-15Clinical Trial Update: Investigation of the Safety and Efficacy of Renzapride in Constipation Predominant Irritable Bowel Syndrome (IBS) [Phase 3]
Phase 3 trial evaluating renzapride for constipation-predominant irritable bowel syndrome has completed.
-
FDA approval · 2007-11-30FDA Approved: DICYCLOMINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for dicyclomine hydrochloride manufactured by Aurobindo Pharma Limited.
-
CLINICAL_TRIALS research · 2007-11-16Clinical Trial Update: Manipulation of Visceral Sensitivity and Immune System in IBS [Phase 4]
This document reports a Phase 4 clinical trial update studying manipulation of visceral sensitivity and the immune system in Irritable Bowel…
-
CLINICAL_TRIALS trial_result · 2007-10-15Clinical Trial Update: 8 Weeks Treatment With DDP225 in Patients With Diarrhea Predominant IBS [Phase 2]
Phase 2 clinical trial update reporting the completion of an 8-week treatment with DDP225 in adults with diarrhea-predominant irritable bowe…
-
CLINICAL_TRIALS trial_result · 2007-10-15Clinical Trial Update: Saccharomyces Boulardii in Diarrhea Dominant Irritable Bowel Syndrome [Phase 4]
Phase 4 clinical trial update assessing Saccharomyces boulardii for diarrhea-dominant irritable bowel syndrome.
-
FDA approval · 2007-10-05FDA Approved: DICYCLOMINE HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for dicyclomine hydrochloride from Hikma Pharmaceuticals USA Inc., enabling the generic product to b…
-
FDA approval · 2007-09-07FDA Approved: DICYCLOMINE HYDROCHLORIDE — Supplemental Application (Lannett Company, Inc.)
FDA approves a supplemental application for dicyclomine hydrochloride from Lannett Company, expanding access to a generic version.